• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

94.37 +2.38 (+2.59%)
Official Closing Price Updated: 7:00 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
June 26, 2026
From Edwards Lifesciences Corporation
Via Business Wire
What's going on in today's pre-market session: S&P500 movers ↗
June 22, 2026
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
June 16, 2026
Via Chartmill
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
June 16, 2026
Via Chartmill
News headline image
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
May 02, 2026
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Corp (NYSE:EW) Shares Surge After Q1 Earnings Beat and Raised Guidance ↗
April 23, 2026
Via Chartmill
Topics Earnings
Edwards Lifesciences Corp (NYSE:EW) Reports Mixed Q4 Results, Misses EPS Estimates ↗
February 10, 2026
Via Chartmill
News headline image
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
April 28, 2026
From Edwards Lifesciences Corporation
Via Business Wire
Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗
April 23, 2026
Via Chartmill
News headline image
Edwards Lifesciences Reports First Quarter Results
April 23, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
April 16, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
April 15, 2026
Discover the top S&P500 movers in Wednesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Topics Lawsuit
News headline image
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)
April 01, 2026
As of April 1, 2026, Becton, Dickinson and Company (NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a... 
Via Finterra
Topics Economy Lawsuit Product Recall
News headline image
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
March 30, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗
March 15, 2026
This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing. 
Via The Motley Fool
News headline image
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗
March 15, 2026
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials. 
Via The Motley Fool
Friday's session: top gainers and losers in the S&P500 index ↗
March 13, 2026
Via Chartmill
News headline image
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
February 26, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
February 20, 2026
Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
February 19, 2026
On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire... 
Via MarketMinute
News headline image
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
February 19, 2026
From Edwards Lifesciences Corporation
Via Business Wire
Exploring the top movers within the S&P500 index during today's session. ↗
February 17, 2026
Via Chartmill
News headline image
The Return of the Mega-Deal: How 2026’s Regulatory Pragmatism is Reshaping Corporate America
February 13, 2026
The U.S. mergers and acquisitions (M&A) landscape has entered a definitive new era in early 2026, marked by what analysts are calling a "Strategic Rebound." After years of aggressive antitrust... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
February 13, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗
February 12, 2026
Via MarketBeat
News headline image
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
February 12, 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume S&P500 stocks in Wednesday's session ↗
February 11, 2026
Via Chartmill
News headline image
Edwards Lifesciences (EW) Earnings Transcript ↗
February 10, 2026
Edwards Lifesciences (EW) Earnings Transcript 
Via The Motley Fool
News headline image
Edwards Lifesciences Reports Fourth Quarter Results
February 10, 2026
From Edwards Lifesciences Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap